Pharmaburst™ 500

Orally Disintegrating Tablet Platform

Pharmaburst 500 is the leading orally disintegrating tablet (ODT) platform, trusted for its performance, versatility, and ability to overcome formulation challenges. Widely adopted, it meets global standards and is used in more than 60 commercial products worldwide.

Pharmaburst 500 enables robust tablets that withstand production and handling while disintegrating quickly for patient comfort, simplifying formulation and accelerating time to market.

Patient Compliance

Rapid disintegration time of 30 seconds or less, crucial for patient compliance

Excellent mouthfeel qualities to help improve patient compliance- making your drug product more successful

Better Drug Loading Capability

Highly compactible- carry high drug loads without increased tablet size

Robust Tablets

Manufacture durable tablets at lower compression forces

Reduce stress on equipment and multiparticulates while ensuring the integrity of the coat is maintained

Ease of Manufacturing

Pharmaburst 500 is designed to be a completely optimized platform that requires little formulation development. Orally disintegrating tablets formulated with Pharmaburst are also easy to manufacture using standard direct compression equipment and processes. Simply add the active, dry blend, and compress.